Biosimilar CT-P13 Matches Infliximab for Crohn ' s Disease Biosimilar CT-P13 Matches Infliximab for Crohn ' s Disease

Crohn ' s disease was effectively and safely treated either with infliximab or with the biosimilar CT-P13, according to an observational cohort study of more than 5000 patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news